Disclosed are negative allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention
本发明涉及负向变构谷
氨酸受体亚型5(mGluR5)的负向变构调节剂;制备该化合物的合成方法;包含该化合物的药物组合物;以及使用该化合物和组合物治疗与谷
氨酸功能障碍相关的神经和精神障碍的方法。该摘要旨在作为特定领域搜索的扫描工具,并不意味着对本发明的限制。